PATRICK DUFFY: Open Payments
NPI 1780748368 · REHOBOTH BEACH, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,911 in 64 payments from 17 companies in 2025. Trend: 2023 $1,701 · 2024 $917 · 2025 $2,911
Food & beverage: $2,745Education: $166
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $925 |
| ABBVIE INC. | 10 | $287 |
| Medtronic, Inc. | 3 | $268 |
| GENZYME CORPORATION | 3 | $267 |
| E.R. Squibb & Sons, L.L.C. | 3 | $242 |
| Amgen Inc. | 5 | $184 |
| UCB, Inc. | 2 | $168 |
| Lilly USA, LLC | 2 | $154 |
| Novartis Pharmaceuticals Corporation | 5 | $99 |
| Galderma Laboratories, L.P. | 1 | $86 |
Products named: TREMFYA, SKYRIZI, Sotyktu, Bimzelx, WAYRILZ, DUPIXENT, EBGLYSS, SOLITAIRE X.
Industry payments across DE — which companies pay providers there.
